Transfer of rofecoxib into human milk

European Journal of Clinical Pharmacology

Volumn 61, Issue 5-6, 2005, Pages 405-408

  Gardiner, Sharon J ^a   Begg, Evan J ^a   Zhang, Mei ^a   Hughes, Ruth C E ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ROFECOXIB;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BREAST FEEDING; BREAST MILK; FEMALE; HUMAN; LACTATION; PRIORITY JOURNAL; WEANING;

ADULT; AREA UNDER CURVE; CYCLOOXYGENASE INHIBITORS; FEMALE; HALF-LIFE; HUMANS; LACTATION; LACTONES; METABOLIC CLEARANCE RATE; MILK, HUMAN; SULFONES;

EID: 27644513760     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0937-2     Document Type: Article

References (13)

1. Anonymous, Merck announces voluntary worldwide withdrawal of Vioxx, 30 September 2004 (press release). Available online at: http://www.vioxx.com/ rofecoxib/vioxx/hcp/hcp_notification_physicians.jsp (accessed 08 October 2004)
2. Topol EJ (2004) Failing the public health-rofecoxib, Merck, and the FDA. New Engl J Med 351(17):1707-1709 (Accessed on 08 October 2004)
3. Anonymous. Merck and Company Inc Vioxx (rofecoxib tablets and oral suspension) [prescribing information], Whitehouse Station, NJ 08889, USA. Available online at: http://www.vio-xx.com/rofecoxib/vioxx/consumer/prescribing- information.jsp (accessed 03 June 2005)
4. Wilson JT, Brown RD, Cherek DR, Dailey JW, Hilman B et al (1980) Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences. Clin Pharmacokinet 5:1-66
5. Bar-Oz B, Bulkowstein M, Benyamini, Greenberg R, Soriano I et al (2003) Use of antibiotic and analgesic drugs during lacation. Drug Saf 26(13):925-935
6. Knoppert DC, Stempak C, Baruchel S, Koren G (2003). Celecoxib in human milk: a case report. Pharmacotherapy 23(1):97-100
7. Zhang M, Moore GA, Gardiner SJ, Begg EJ (2004). Determination of rofecoxib in human plasma and breast milk by high-performance liquid chromatographic assay. J Chromatogr B 807(2):217-221
8. Bennett PN (1996) Drugs and human lactation, 2nd edn. Elsevier, Amsterdam
9. Pattargarn A, Alon US (2003) Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor. Pediatr Nephrol 18:1073-1076
10. Haas NA, Nossal R, Schneider CH, Lewin MAG, Ocker V et al (2003) Successful management of an extreme example of neonatal hyperprostaglandin-E syndrome (Bartter's syndrome) with the new cyclooxygenase-2 inhibitor rofecoxib. Pediatr Crit Care Med 4:249-251
11. Vaisbich MH, Fujimura MD, Koch VH (2004) Bartter syndrome: benefits and side effects of long-term treatment. Pediatr Nephrol 19(8):858-863
12. Anonymous. Pfizer, Celebrex (celecoxib capsules) [prescribing information], Chicago, IL 60680, USA. Available online at: http://www.fda.gov/ cder/foi/label/1998/209981bl.pdf (accessed 26 September 2004)
13. Neville MC, Allen JC, Archer PC, Casey CE, Seacat J et al (1991) Studies in human lactation: milk volume and nutrient composition during weaning and lactogenesis. Am J Clin Nutr 54(1):81-92